Adriana Di Benedetto

Adriana Di Benedetto


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in International Journal of Medical Sciences
Verified
Journal Article
Open access
ABAdriana Di Benedetto
Adriana Di Benedetto
FPFrancesca Posa
Francesca Posa
SMSalvatore De Maria
Salvatore De Maria
GRGiampietro Ravagnan
Giampietro Ravagnan
ABAndrea Ballini
Andrea Ballini
Giorgio MoriGiorgio Mori
Giorgio Mori
Bone loss and fractures are consequences of aging, diseases or traumas. Furthermore the increased number of aged people due to the rise of life expectancy, needs more strategies to limit the bone loss and regenerate the lost tissue, ameliorating the life quality of patients. A great interest for non-pharmacological therapies based on natural compounds is emerging and focusing on the oligostilbene Polydatin, present in many kinds of fruits and vegetables, when resveratrol particularly in red wines. These molecules have been extensively studied due to their antioxidant and anti-inflammatory effects, showing more recently Resveratrol the ability to enhance osteogenic differentiation and bone formation. However, the clinical applications of Resveratrol are limited due to its low bioavailability and rapid metabolism, while its natural glycosilated precursor Polydatin shows better metabolic stability and major abundance in fresh fruits and vegetables. Nevertheless the role of Polydatin on osteogenic differentiation is still unexplored. Mesenchymal stem cells (MSCs) from dental tissues, such as dental bud stem cells (DBSCs), are able to differentiate toward osteogenic lineage: thus we investigated how Resveratrol and Polydatin influence the differentiation of DBSCs, eventually affecting bone formation. Our results showed that Polydatin increases MSCs osteogenic differentiation sharing similar properties with Resveratrol. These results encourage to deepen the effects of this molecule on bone health and its associated mechanisms of action, wishing for the future a successful use in bone loss prevention and therapy.

9 October 2020 in Materials
Verified
Journal Article
Open access
PDF file
FPFrancesca Posa
Francesca Posa
ABAdriana Di Benedetto
Adriana Di Benedetto
GRGiampietro Ravagnan
Giampietro Ravagnan
ECElisabetta Ada Cavalcanti-Adam
Elisabetta Ada Cavalcanti-Adam
Lorenzo Lo MuzioLorenzo Lo Muzio
Lorenzo Lo Muzio
Giorgio MoriGiorgio Mori
Giorgio Mori
Diseases determining bone tissue loss have a high impact on people of any age. Bone healing can be improved using a therapeutic approach based on tissue engineering. Scientific research is demonstrating that among bone regeneration techniques, interesting results, in filling of bone lesions and dehiscence have been obtained using adult mesenchymal stem cells (MSCs) integrated with biocompatible scaffolds. The geometry of the scaffold has critical effects on cell adhesion, proliferation and differentiation. Many cytokines and compounds have been demonstrated to be effective in promoting MSCs osteogenic differentiation. Oligostilbenes, such as Resveratrol (Res) and Polydatin (Pol), can increase MSCs osteoblastic features. 3D printing is an excellent technique to create scaffolds customized for the lesion and thus optimized for the patient. In this work we analyze osteoblastic features of adult MSCs integrated with 3D-printed polycarbonate scaffolds differentiated in the presence of oligostilbenes.